Showing results (101-110 of 280) with videos related to
Sort By:
Pageof 28
Cancer|February 26, 2016
Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national databaseSean A Fletcher, Angel M Cronin, Amer M Zeidan, et al.Blood Reviews|November 20, 2020
Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolvedRory M Shallis, Robert P Gale, Hillard M Lazarus, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 8, 2019
Physician Experience and Risk of Rituximab Discontinuation in Older Adults With Non-Hodgkin's LymphomaScott F Huntington, Jessica R Hoag, Rong Wang, et al.Leukemia & Lymphoma|December 28, 2019
Hypomethylating agent (HMA) therapy use and survival in older adults with Refractory Anemia with Excess Blasts (RAEB) in the United States (USA): a large propensity score-matched population-based study<sup>†</sup>Amy J Davidoff, Xin Hu, Jan Philipp Bewersdorf, et al.Cancer|June 17, 2017
Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based studyAmer M Zeidan, Xin Hu, Jessica B Long, et al.SLAS Discovery : Advancing Life Sciences R & D|October 23, 2025
High-throughput combination screening of Pidnarulex and other G-quadruplex ligands in multi-cell type tumor spheroidsThomas S Dexheimer, Nathan P Coussens, Thomas Silvers, et al.Ejhaem|July 18, 2022
Predictors of vascular disease in myelodysplastic syndromesMark G Faber, David R Lloyd, Abhay Singh, et al.Leukemia Research|May 6, 2021
A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemiaPankit Vachhani, Jeffrey Baron, Craig W Freyer, et al.The Journal of Biological Chemistry|September 10, 2003
Central role of Fas-associated death domain protein in apoptosis induction by the mitogen-activated protein kinase kinase inhibitor CI-1040 (PD184352) in acute lymphocytic leukemia cells in vitroXue Wei Meng, Joya Chandra, David Loegering, et al.Leukemia & Lymphoma|June 8, 2019
RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysisAmer M Zeidan, Weiwei Zhu, Maximilian Stahl, et al.Pageof 28